Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...
Main Authors: | Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Pulmonary Circulation |
Subjects: | |
Online Access: | https://doi.org/10.1002/pul2.12141 |
Similar Items
-
The PH‐ILD Detection tool: External validation and use in patients with ILD
by: Raj Parikh, et al.
Published: (2023-07-01) -
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
by: Julia McSweeney, et al.
Published: (2023-04-01) -
Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
by: Jenna M. Faircloth, et al.
Published: (2023-03-01) -
Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
by: Jenna M. Faircloth, et al.
Published: (2023-08-01) -
Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
by: Abdullah A. Alqarni, et al.
Published: (2023-08-01)